Verition Fund Management LLC Catalyst Pharmaceuticals, Inc. Transaction History
Verition Fund Management LLC
- $20.3 Billion
- Q2 2025
A detailed history of Verition Fund Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 19,445 shares of CPRX stock, worth $408,539. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,445
Previous 29,311
33.66%
Holding current value
$408,539
Previous $710,000
40.7%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CPRX
# of Institutions
384Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$393 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$184 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$115 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$68.3 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$66.9 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.16B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...